Cargando…

Epistatic interactions in idiopathic pulmonary arterial hypertension

BACKGROUND: Idiopathic pulmonary arterial hypertension (IPAH) is a poorly understood complex disorder, which results in progressive remodeling of the pulmonary artery that ultimately leads to right ventricular failure. A two-hit hypothesis has been implicated in pathogenesis of IPAH, according to wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Vadapalli, Shivani, Satyanarayana, M. L., Chaitra, K. L., Rani, H. Surekh, Sastry, B.K.S., Nallari, Pratibha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385180/
https://www.ncbi.nlm.nih.gov/pubmed/22754222
http://dx.doi.org/10.4103/0971-6866.96652
_version_ 1782236816460480512
author Vadapalli, Shivani
Satyanarayana, M. L.
Chaitra, K. L.
Rani, H. Surekh
Sastry, B.K.S.
Nallari, Pratibha
author_facet Vadapalli, Shivani
Satyanarayana, M. L.
Chaitra, K. L.
Rani, H. Surekh
Sastry, B.K.S.
Nallari, Pratibha
author_sort Vadapalli, Shivani
collection PubMed
description BACKGROUND: Idiopathic pulmonary arterial hypertension (IPAH) is a poorly understood complex disorder, which results in progressive remodeling of the pulmonary artery that ultimately leads to right ventricular failure. A two-hit hypothesis has been implicated in pathogenesis of IPAH, according to which the vascular abnormalities characteristic of PAH are triggered by the accumulation of genetic and/or environmental insults in an already existing genetic background. The multifactor dimensionality reduction (MDR) analysis is a statistical method used to identify gene–gene interaction or epistasis and gene–environment interactions that are associated with a particular disease. The MDR method collapses high-dimensional genetic data into a single dimension, thus permitting interactions to be detected in relatively small sample sizes. AIM: To identify and characterize polymorphisms/genes that increases the susceptibility to IPAH using MDR analysis. MATERIALS AND METHODS: A total of 77 IPAH patients and 100 controls were genotyped for eight polymorphisms of five genes (5HTT, EDN1, NOS3, ALK-1, and PPAR-γ2). MDR method was adopted to determine gene–gene interactions that increase the risk of IPAH. RESULTS: With MDR method, the single-locus model of 5HTT (L/S) polymorphism and the combination of 5HTT(L/S), EDN1(K198N), and NOS3(G894T) polymorphisms in the three-locus model were attributed to be the best models for predicting susceptibility to IPAH, with a P value of 0.05. CONCLUSION: MDR method can be useful in understanding the role of epistatic and gene–environmental interactions in pathogenesis of IPAH.
format Online
Article
Text
id pubmed-3385180
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-33851802012-07-02 Epistatic interactions in idiopathic pulmonary arterial hypertension Vadapalli, Shivani Satyanarayana, M. L. Chaitra, K. L. Rani, H. Surekh Sastry, B.K.S. Nallari, Pratibha Indian J Hum Genet Original Article BACKGROUND: Idiopathic pulmonary arterial hypertension (IPAH) is a poorly understood complex disorder, which results in progressive remodeling of the pulmonary artery that ultimately leads to right ventricular failure. A two-hit hypothesis has been implicated in pathogenesis of IPAH, according to which the vascular abnormalities characteristic of PAH are triggered by the accumulation of genetic and/or environmental insults in an already existing genetic background. The multifactor dimensionality reduction (MDR) analysis is a statistical method used to identify gene–gene interaction or epistasis and gene–environment interactions that are associated with a particular disease. The MDR method collapses high-dimensional genetic data into a single dimension, thus permitting interactions to be detected in relatively small sample sizes. AIM: To identify and characterize polymorphisms/genes that increases the susceptibility to IPAH using MDR analysis. MATERIALS AND METHODS: A total of 77 IPAH patients and 100 controls were genotyped for eight polymorphisms of five genes (5HTT, EDN1, NOS3, ALK-1, and PPAR-γ2). MDR method was adopted to determine gene–gene interactions that increase the risk of IPAH. RESULTS: With MDR method, the single-locus model of 5HTT (L/S) polymorphism and the combination of 5HTT(L/S), EDN1(K198N), and NOS3(G894T) polymorphisms in the three-locus model were attributed to be the best models for predicting susceptibility to IPAH, with a P value of 0.05. CONCLUSION: MDR method can be useful in understanding the role of epistatic and gene–environmental interactions in pathogenesis of IPAH. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3385180/ /pubmed/22754222 http://dx.doi.org/10.4103/0971-6866.96652 Text en Copyright: © Indian Journal of Human Genetics http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Vadapalli, Shivani
Satyanarayana, M. L.
Chaitra, K. L.
Rani, H. Surekh
Sastry, B.K.S.
Nallari, Pratibha
Epistatic interactions in idiopathic pulmonary arterial hypertension
title Epistatic interactions in idiopathic pulmonary arterial hypertension
title_full Epistatic interactions in idiopathic pulmonary arterial hypertension
title_fullStr Epistatic interactions in idiopathic pulmonary arterial hypertension
title_full_unstemmed Epistatic interactions in idiopathic pulmonary arterial hypertension
title_short Epistatic interactions in idiopathic pulmonary arterial hypertension
title_sort epistatic interactions in idiopathic pulmonary arterial hypertension
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385180/
https://www.ncbi.nlm.nih.gov/pubmed/22754222
http://dx.doi.org/10.4103/0971-6866.96652
work_keys_str_mv AT vadapallishivani epistaticinteractionsinidiopathicpulmonaryarterialhypertension
AT satyanarayanaml epistaticinteractionsinidiopathicpulmonaryarterialhypertension
AT chaitrakl epistaticinteractionsinidiopathicpulmonaryarterialhypertension
AT ranihsurekh epistaticinteractionsinidiopathicpulmonaryarterialhypertension
AT sastrybks epistaticinteractionsinidiopathicpulmonaryarterialhypertension
AT nallaripratibha epistaticinteractionsinidiopathicpulmonaryarterialhypertension